2021
Chronic refractory angina pectoris treated by bilateral stereotactic radiosurgical stellate ganglion ablation: first-in-man case report
HUDEC, Miroslav, Otakar JIRAVSKÝ, Radim ŠPAČEK, Radek NEUWIRTH, Lukas KNYBEL et. al.Základní údaje
Originální název
Chronic refractory angina pectoris treated by bilateral stereotactic radiosurgical stellate ganglion ablation: first-in-man case report
Autoři
HUDEC, Miroslav (203 Česká republika, domácí), Otakar JIRAVSKÝ (203 Česká republika, domácí), Radim ŠPAČEK (203 Česká republika), Radek NEUWIRTH (203 Česká republika, domácí), Lukas KNYBEL (203 Česká republika), Libor ŠKŇOUŘIL (203 Česká republika), Jakub CVEK (203 Česká republika) a Roman MIKLÍK (203 Česká republika, garant)
Vydání
European Heart Journal - Case Reports, Oxford, OXFORD UNIV PRESS, 2021, 2514-2119
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Kód RIV
RIV/00216224:14110/21:00122283
Organizační jednotka
Lékařská fakulta
UT WoS
000696197100040
Klíčová slova anglicky
Upper thoracic sympathetic system; Stellate ganglion blockade; Refractory angina; Stereotactic radiosurgery; Case report
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 29. 3. 2022 12:52, Mgr. Tereza Miškechová
Anotace
V originále
Background Refractory angina pectoris (AP) significantly impairs quality of life in patients with chronic coronary syndrome. Several minimally invasive methods (coronary sinus reducer, cell therapy, laser or shockwave revascularization, and spinal cord stimulation) or non-invasive methods (external counterpulzation) have been studied. However, their routine clinical use has not been widely implemented. Surgical or endoscopic sympathectomy is feasible for permanently relieving angina, but is often contraindicated due to the extent of complications associated with it. Neuromodulation by anaesthetic blockade of the left-sided stellate ganglion (SG) has been shown to relieve angina for days or weeks. To provide a long-term anti-anginal effect, novel pharmacological (phenol-based) or radiofrequency ablation techniques have been individually used to permanently destroy sympathetic pathways. Case summary We describe a first-in-man use of stereotactic radiosurgical SG ablation using a linear accelerator (CyberKnife) in a heart failure patient after myocardial infarction with chronic refractory AP. Repeated anaesthetic SG blockade in this patient resulted in a significant, but only short-term, clinical improvement. The left, and subsequently the right, SG was ablated by targeted irradiation. During the 1-year follow-up, the patient remained without angina. We did not observe any clinically relevant early or late complications. Atrial fibrillation that developed 2 months after the second procedure was deemed to be associated with a natural progression of co-existing heart failure. Discussion We conclude that stereotactic radiosurgical SG ablation has the potential to become a minimally invasive and low-risk procedure to treat refractory angina patients. However, this procedure needs to be evaluated in larger patient populations.